338 related articles for article (PubMed ID: 29380183)
1. Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.
Kumar K; Raj P; Chandnani N; Agarwal A
Int Ophthalmol; 2019 Feb; 39(2):465-470. PubMed ID: 29380183
[TBL] [Abstract][Full Text] [Related]
2. Adult coats' disease successfully managed with the dexamethasone intravitreal implant (ozurdex®) combined with retinal photocoagulation.
Martínez-Castillo S; Gallego-Pinazo R; Dolz-Marco R; Marín-Lambíes C; Díaz-Llopis M
Case Rep Ophthalmol; 2012 Jan; 3(1):123-7. PubMed ID: 22548046
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.
Kodama A; Sugioka K; Kusaka S; Matsumoto C; Shimomura Y
BMC Ophthalmol; 2014 Mar; 14():36. PubMed ID: 24666524
[TBL] [Abstract][Full Text] [Related]
4. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease.
Raoof N; Quhill F
Middle East Afr J Ophthalmol; 2013; 20(3):256-8. PubMed ID: 24014992
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.
Zhang L; Ke Y; Wang W; Shi X; Hei K; Li X
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1339-1346. PubMed ID: 29549425
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease.
Park S; Cho HJ; Lee DW; Kim CG; Kim JW
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1511-1517. PubMed ID: 26631136
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.
Matos R; Beato J; Silva M; Silva S; Brandão E; Falcão-Reis F; Penas S
Ophthalmic Genet; 2017; 38(5):490-493. PubMed ID: 28121209
[TBL] [Abstract][Full Text] [Related]
9. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
Li S; Deng G; Liu J; Ma Y; Lu H
BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
[TBL] [Abstract][Full Text] [Related]
10. A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset Coats' disease.
Wang KY; Cheng CK
J Ocul Pharmacol Ther; 2011 Oct; 27(5):525-30. PubMed ID: 21951171
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Coats' Disease With Combination Therapy of Intravitreal Bevacizumab, Laser Photocoagulation, and Sub-Tenon Corticosteroids.
Sein J; Tzu JH; Murray TG; Berrocal AM
Ophthalmic Surg Lasers Imaging Retina; 2016 May; 47(5):443-9. PubMed ID: 27183548
[TBL] [Abstract][Full Text] [Related]
12. Early onset coats' disease initially treated as unilateral ROP at 39 weeks postmenstrual age: a case report.
Peng J; Zhang Q; Chen C; Huang Q; Li Y; Zhao P
BMC Ophthalmol; 2017 Aug; 17(1):145. PubMed ID: 28814287
[TBL] [Abstract][Full Text] [Related]
13. Secondary Coats' response to retinal vasculitis managed with bevacizumab.
Chaudhary P; Varshney A; Videkar C
Indian J Ophthalmol; 2018 Sep; 66(9):1355-1357. PubMed ID: 30127171
[TBL] [Abstract][Full Text] [Related]
14. [Adjuvant anti-VEGF therapy in Coats' disease].
Fiorentzis M; Stavridis E; Seitz B; Viestenz A
Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
[TBL] [Abstract][Full Text] [Related]
15. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
16. Successful use of intravitreal ranibizumab injection and combined treatment in the management of Coats' disease.
Yang Q; Wei W; Shi X; Yang L
Acta Ophthalmol; 2016 Jun; 94(4):401-6. PubMed ID: 27150442
[TBL] [Abstract][Full Text] [Related]
17. Coats' disease of adult-onset in 48 eyes.
Rishi E; Rishi P; Appukuttan B; Uparkar M; Sharma T; Gopal L
Indian J Ophthalmol; 2016 Jul; 64(7):518-23. PubMed ID: 27609165
[TBL] [Abstract][Full Text] [Related]
18. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.
Shields CL; Udyaver S; Dalvin LA; Lim LS; Atalay HT; L Khoo CT; Mazloumi M; Shields JA
Indian J Ophthalmol; 2019 Jun; 67(6):772-783. PubMed ID: 31124485
[TBL] [Abstract][Full Text] [Related]
19. Role of intravitreal bevacizumab in adult onset Coats' disease.
Goel N; Kumar V; Seth A; Raina UK; Ghosh B
Int Ophthalmol; 2011 Jun; 31(3):183-90. PubMed ID: 21437759
[TBL] [Abstract][Full Text] [Related]
20. Retinoschisis in the setting of Coats' disease.
Yannuzzi NA; Tzu JH; Hess DJ; Berrocal AM
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):172-4. PubMed ID: 24635161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
